Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00826007 · ClinicalTrials.gov registry record

Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes

A clinical trial, sponsored by Corewell Health East.

Completed
Registry status
587
Enrollment target

NCT00826007: Completed study, sponsored by Corewell Health East.

NCT00826007 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 587 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00826007 has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
587 participants
Enrollment target

Study Summary

The purpose of the study is to review incidences of mild, moderate, and severe hypoglycemia in preoperative care units, operating rooms, and postanesthesia care units and analyze associated conditions and treatment.

Primary Outcome

Blood glucose values \<70 mg/dl

Trial Details

FieldValue
Enrollment Target 587 participants
Start Date 2009-01
Est. Completion 2011-07
Corewell Health East

106 total trials

What the finished NCT00826007 record still lists

NCT00826007 is an observational study that tracks outcomes without assigning an intervention. The registered 587 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00826007 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00826007 about?

NCT00826007 is a clinical study titled "Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes". The purpose of the study is to review incidences of mild, moderate, and severe hypoglycemia in preoperative care units, operating rooms, and postanesthesia care units and analyze associated conditions and treatment.

What is the current status of trial NCT00826007?

This trial is currently completed. The enrollment target is 587 participants. The study started on 2009-01. Estimated completion is 2011-07.

Who is sponsoring clinical trial NCT00826007?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06921603 · 588 participants · NA

    POCUS-Guided Diuresis for Decompensated Heart Failure

  • NCT06986954 · 588 participants

    Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

  • NCT04134260 · 586 participants · Phase 3

    Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

  • NCT06100770 · 586 participants

    Aveir AR Coverage With Evidence Development (CED) Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00826007, the US trial registry maintained by the National Library of Medicine. NCT00826007 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.